Broshy Eran
CIK 0001256230
Director
Filings
12
Latest May 15, 2026
Issuers covered
2
Showing
12 of 12
Page 1
Track record
10 of 10 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 10 | 80% | +1.9% | +4.4% | +5.6% | -11.2% |
| 90 days | 10 | 20% | -3.8% | -5.4% | +4.5% | -8.7% |
| 180 days | 10 | 100% | +11.8% | +10.7% | +17.8% | +7.6% |
| 365 days | 2 | 0% | -19.0% | -19.0% | -17.7% | -20.2% |
Issuers
Companies where Broshy Eran has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TBPH | Theravance Biopharma, Inc. | 7 | Dec 1, 2025 |
| CERT | Certara, Inc. | 5 | May 15, 2026 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|